OAT PINs and DINs

The tables below provide Product Identification Numbers (PINs) and Drug Identification Numbers (DINs) for PharmaCare claims for opioid agonist treatment (OAT). PINs listed are for OAT claims only.

For more information on OAT and current methadone formulations, please see the BC Centre on Substance Use bulletin (PDF, 480 KB).

On this page:

---

Interaction fees

For all eligible direct interaction OAT claims, PharmaCare pays an interaction fee to pharmacies that are:

• Enrolled in the Methadone Maintenance Sub-Class; and
• Dispensing methadone with direct interaction

Plan B claims are excluded from interaction fees. Eligible claims include those for Fair PharmaCare beneficiaries who have not met their deductible.

---

Pain indications

Many of the drugs listed below may be prescribed for pain. If a prescription is for pain, enter the transaction in PharmaNet with the corresponding DIN.

Do not use OAT PINs for pain indications.

Direct interaction

Drug	PIN for OAT Claims	Plan Coverage	Claim Submission Requirements
Methadose™ 10 mg/mL (cherry)	66999997	Plans B, C, G, P, W and Fair PharmaCare. Maximum one dispensing fee and one interaction fee per patient per day.	Claim quantity must be submitted as total mLs. SIG must include dose in mg and mL (e.g., Take 5 mLs (50 mg) once daily.) SIG must include the start and end dates of the prescription. Carries must be claimed as single multiple-day supply for drug cost, plus a single dispensing fee. A single interaction fee will be paid for the first witnessed dose. Split doses must be claimed as a single multiple-dose claim for drug cost, plus a single dispensing fee. A single interaction fee will be paid for the first witnessed dose.
Metadol-D® 10 mg/mL (unflavoured)	67000005
methadone (Sterinova®) 10 mg/mL	67000017

Direct interaction with delivery

Drug	PIN for OAT Claims	Plan Coverage	Claim Submission Requirements
Methadose™ 10 mg/mL (cherry)	66999999	Plans B, C, G, P, W and Fair PharmaCare. Maximum one dispensing fee and one interaction fee per patient per day.	Claim quantity must be submitted as total mLs. SIG must include dose in mg and mL (e.g., Take 5 mLs (50 mg) once daily.) SIG must include the start and end dates of the prescription. Carries must be claimed as single multiple-day supply for drug cost, plus a single dispensing fee. A single interaction fee will be paid for the first witnessed dose. Split doses must be claimed as a single multiple-dose claim for drug cost, plus a single dispensing fee. A single interaction fee will be paid for the first witnessed dose.
Metadol-D® 10 mg/mL (unflavoured)	67000007
methadone (Sterinova®) 10 mg/mL	67000018

No direct interaction

Drug	PIN for OAT Claims	Plan Coverage	Claim Submission Requirements
Methadose™ 10 mg/mL (cherry)	66999998	Plans B, C, G, P, W and Fair PharmaCare.	Claim quantity must be submitted as total mLs. SIG must include dose in mg and mL (e.g., Take 5 mLs (50 mg) once daily.) SIG must include the start and end dates of the prescription. Carries must be claimed as single multiple-day supply for drug cost, plus a single dispensing fee. A single interaction fee will be paid for the first witnessed dose. Split doses must be claimed as a single multiple-dose claim for drug cost, plus a single dispensing fee.
Metadol-D® 10 mg/mL (unflavoured)	67000006
methadone (Sterinova®) 10 mg/mL	67000020

No direct interaction with delivery

Drug	PIN for OAT Claims	Plan Coverage	Claim Submission Requirements
Methadose™ 10 mg/mL (cherry)	67000000	Plans B, C, G, P, W and Fair PharmaCare.	Claim quantity must be submitted as total mLs. SIG must include dose in mg and mL (e.g., Take 5 mLs (50 mg) once daily.) SIG must include the start and end dates of the prescription. Carries must be claimed as single multiple-day supply for drug cost, plus a single dispensing fee. A single interaction fee will be paid for the first witnessed dose. Split doses must be claimed as a single multiple-dose claim for drug cost, plus a single dispensing fee.
Metadol-D® 10 mg/mL (unflavoured)	67000008
methadone (Sterinova®) 10 mg/mL	67000019

Non-benefit methadone

Drug	PIN for OAT Claims	Plan Coverage	Claim Submission Requirements
Methadose™ 10 mg/mL sugar-free with direct interaction	67000001	Non-benefit. Special Authority coverage required under plans B, C, G, P, W and Fair PharmaCare.	See relevant dispense type above for submission requirements.
Methadose™ 10 mg/mL sugar-free delivery with direct interaction	67000003
Methadose™ 10 mg/mL sugar-free without direct interaction	67000002
Methadose™ 10 mg/mL sugar-free delivery without direct interaction	67000004
Compounded methadone 10 mg/mL with direct interaction	67000013	Non-benefit. Last-resort, exceptional coverage only. Special Authority required. Dispensing pharmacies must order compounded methadone from the central compounding pharmacy. Please contact the BCCSU or the BCPhA for details.	See relevant dispense type above for submission requirements.
Compounded methadone 10 mg/mL delivery with direct interaction	67000014
Compounded methadone 10 mg/mL without direct interaction	67000016
Compounded methadone 10 mg/mL delivery without direct interaction	67000015

Buprenorphine/naloxone, suboxone, and Kadian^® DINs and PINs

Drug	DIN/PIN for OAT Claims	Plan Coverage	Claim Submission Requirements
buprenorphine/naloxone SL 2 mg/0.5 mg generics	ACT 02453908	Covered under plans B, C, G, P, W, and Fair PharmaCare. No interaction fee paid for witnessed ingestion.	Claim quantity must be submitted as the number of tablets. SIG should include start and end dates as best practice (not mandatory).
	PMS 02424851
buprenorphine/naloxone SL 8 mg/2 mg generics	ACT 02453916
	PMS 02424878
Suboxone® buprenorphine/naloxone 2 mg/0.5 mg SL	02295695	Suboxone® is a partial benefit under plans B, C, G, P, W, and Fair PharmaCare. No interaction fee paid for witnessed ingestion.	Claim quantity must be submitted as the number of tablets. SIG should include start and end dates as best practice (not mandatory).
Suboxone® buprenorphine/naloxone 8 mg/2 mg SL	02295709
Suboxone® buprenorphine/naloxone 12 mg/3 mg SL	02468085	Exceptional Special Authority coverage required under plans B, C, G, P, W and Fair PharmaCare. No interaction fee paid for witnessed ingestion.
Suboxone® buprenorphine/naloxone 16 mg/4 mg SL	02468093
Kadian® slow-release oral morphine 10 mg capsule	22123349 (PIN)	Covered for OAT under plans B, C, G, P, W and Fair PharmaCare. No interaction fee paid for witnessed ingestion.	Submit using PharmaCare PINs if for OAT. Claim quantity must be submitted as the number of capsules. SIG should include start and end dates as best practice (not mandatory).
Kadian® slow-release oral morphine 20 mg capsule	22123346 (PIN)
Kadian® slow-release oral morphine 50 mg capsule	22123347 (PIN)
Kadian® slow-release oral morphine 100 mg capsule	22123348 (PIN)

Injectable opioid agonist treatment (iOAT)

• iOAT considerations (PDF, 168KB)